Literature DB >> 5791002

Myasthenia gravis with a myeloma-type, gamma-G (IgG) immunoglobulin abnormality.

L P Rowland, E F Osserman, W B Scharfman, R F Balsam, S Ball.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5791002     DOI: 10.1016/0002-9343(69)90078-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Serum immunogloblin levels in myasthenia gravis, polymyositis, and dermatomyositis.

Authors:  R P Lisak; B Zweiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

2.  Serum IgG, IgA and IgM concentration in 1,038 patients with various neurological disorders.

Authors:  O J Kolar; A T Ross; H Gilliam
Journal:  Z Neurol       Date:  1972

3.  Immunological studies in patients with juvenile-onset myasthenia gravis and in their relatives.

Authors:  S Bundey; D Doniach; J F Soothill
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

4.  Anti-acetylcholine receptor antibodies.

Authors:  A Vincent; J Newsom Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

5.  An Unusual Presentation of Multiple Myeloma.

Authors:  Ishan Parekh; Zaheer A Virani; Prashant Rajput; Hepal Vora; Shruti Tapiawala; Bharat V Shah
Journal:  Indian J Nephrol       Date:  2022-01-05

Review 6.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25

7.  Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report.

Authors:  Shoko Sakano; Hirofumi Matsuyama; Hidehiro Ishikawa; Akihiro Shindo; Yuichiro Ii; Keita Matsuura; Minoru Mizutani; Norikazu Kawada; Hidekazu Tomimoto
Journal:  BMC Neurol       Date:  2020-06-12       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.